EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Relationship between Respiratory Microbiome and Systemic Inflammatory Markers in COPD: A Pilot Study

Carme Casadevall iD, Sara Quero iD, Laura Millares, Rosa Faner, Borja G Cosío iD, Germán Peces-Barba, Ady Castro-Acosta, Concepción Montón, Alexandre Palou, Sergi Pascual-Guardia, Alvar Agustí, Joaquim Gea und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Carme Casadevall und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hospital del Mar Research Institute (IMIM), Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Microbiota, Sputum, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, co-funded by the European Un-ion, Spanish Ministry of Economy and Competitivity, co-funded by the European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The respiratory microbiome may influence the development and progression of COPD by modulating local immune and inflammatory events. We aimed to investigate whether relative changes in respiratory bacterial abundance are also associated with systemic inflammation, and explore their relationship with the main clinical COPD phenotypes. Multiplex analysis of inflammatory markers and transcript eosinophil-related markers were analyzed on peripheral blood in a cohort of stable COPD patients (n = 72). Respiratory microbiome composition was analyzed by 16S rRNA microbial sequencing on spontaneous sputum. Spearman correlations were applied to test the relationship between the microbiome composition and systemic inflammation. The concentration of the plasma IL-8 showed an inverted correlation with the relative abundance of 17 bacterial genera in the whole COPD cohort. COPD patients categorized as eosinophilic showed positive relationships with blood eosinophil markers and inversely correlated with the degree of airway obstruction and the number of exacerbations during the previous year. COPD patients categorized as frequent exacerbators were enriched with the bacterial genera Pseudomonas which, in turn, was positively associated with the severity of airflow limitation and the prior year’s exacerbation history. The associative relationships of the sputum microbiome with the severity of the disease emphasize the relevance of the interaction between the respiratory microbiota and systemic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveMicrobiotaSputumBiomarkersHumansMaleFemaleAgedPilot ProjectsMiddle AgedInflammationRNA, Ribosomal, 16SInterleukin-8Eosinophils

Stichwörter der Autor:innen

COPDeosinophilsfrequent exacerbatorsrespiratory microbiomesystemic inflammation

Substanzen

BiomarkersRNA, Ribosomal, 16SInterleukin-8

Autor:innen und Institutionen

  • Hospital del Mar Research Institute (IMIM), Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.
  • Centro de Investigación Biomédica en Red, Área de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.
  • Airway Inflammation Research Group, Parc Taulí Research and Innovation Institute-I3PT-Parc Taulí Foundation, 08208 Sabadell, Spain.
  • Catalan Institute of Oncology-ICO, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Servei de Pneumologia (Institut Clínic de Respiratori) and Dispositiu Transversal d'Hospitalització a Domicili (Direcció Mèdica i d'Infermeria), Hospital Clínic-Fundació Clínic per la Recerca Biomèdica, Universitat de B…

ORCID-Profile: Carme Casadevall, Sara Quero, Borja G Cosío

Förderung

  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
  • Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, co-funded by the European Un-ion
  • Spanish Ministry of Economy and Competitivity, co-funded by the European Union
  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • Sociedad Española de Neumología y Cirugía Torácica
  • Societat Catalana de Pneumologia
  • Centro de Investigación Biomédica en Red, Área de Enfermedades Respiratorias (CIBERES)
  • Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, co-funded by the European Union

Zitieren

APA

Casadevall, C., Quero, S., Millares, L., Faner, R., Cosío, B. G., Peces-Barba, G., Castro-Acosta, A., Montón, C., Palou, A., Pascual-Guardia, S., Agustí, A., Gea, J., Monsó, E., & On Behalf Of The Biomepoc Group (2024). Relationship between Respiratory Microbiome and Systemic Inflammatory Markers in COPD: A Pilot Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158467

Vancouver

Casadevall C, Quero S, Millares L, Faner R, Cosío BG, Peces-Barba G, et al. Relationship between Respiratory Microbiome and Systemic Inflammatory Markers in COPD: A Pilot Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158467

BibTeX
@article{Casadevall2024,
  author = {Casadevall, Carme and Quero, Sara and Millares, Laura and Faner, Rosa and Cosío, Borja G and Peces-Barba, Germán and Castro-Acosta, Ady and Montón, Concepción and Palou, Alexandre and Pascual-Guardia, Sergi and Agustí, Alvar and Gea, Joaquim and Monsó, Eduard and On Behalf Of The Biomepoc Group},
  title = {Relationship between Respiratory Microbiome and Systemic Inflammatory Markers in COPD: A Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158467}
}
Kostenlos starten →